Chart: Biotech Stocks - Gross Profit Margins
Submit
an article to
an article to
-
Font Size:
-
Print
- TweetThis
Gross profit margins in the Biotech sector ranged from 100% ((ALXN), (NBIX), (INCY)) down to 35.0% (NABI), with the median for the group at 84.1%.
Data in table version -- click on a ticker for opinion and analysis of the company:
| Total | Gross | Gross | |||
|---|---|---|---|---|---|
| Quarter | Revenue | Profit | Profit | ||
| Ticker | Company | Ending | ($mm) | ($mm) | Margin (%) |
| AFFX | Affymetrix Inc. | 03/31/06 | $86.39 | $59.29 | 68.6%
|
| ALXN | Alexion Pharmaceuticals Inc. | 03/31/06 | $0.77 | $0.77 | 100.0%
|
| AMGN | Amgen Inc. | 03/31/06 | $3217.00 | $2665.00 | 82.8%
|
| AMLN | Amylin Pharmaceuticals Inc. | 03/31/06 | $82.35 | $72.60 | 88.2%
|
| BIIB | Biogen Idec Inc. | 03/31/06 | $611.18 | $547.68 | 89.6%
|
| BMRN | BioMarin Pharmaceutical Inc. | 12/31/05 | $9.48 | $9.25 | 97.6%
|
| BSTE | Biosite Incorporated | 03/31/06 | $79.33 | $56.23 | 70.9%
|
| CELG | Celgene Corporation | 03/31/06 | $181.84 | $151.70 | 83.4%
|
| DNA | Genentech Inc. | 03/31/06 | $1986.00 | $1724.00 | 86.8%
|
| ELN | Elan Corp. plc | 03/31/06 | $134.30 | $86.50 | 64.4%
|
| GILD | Gilead Sciences Inc. | 03/31/06 | $692.88 | $609.32 | 87.9%
|
| GPRO | Gen-Probe Inc. | 03/31/06 | $86.26 | $60.28 | 69.9%
|
| IMCL | Imclone Systems Inc. | 03/31/06 | $245.13 | $194.58 | 79.4%
|
| INCY | Incyte Corp. | 12/31/05 | $1.03 | $1.03 | 100.0%
|
| ISTA | ISTA Pharmaceuticals Inc. | 12/31/05 | $3.68 | $2.45 | 66.6%
|
| KOSP | KOS Pharmaceuticals Inc. | 12/31/05 | $213.92 | $187.18 | 87.5%
|
| MEDI | MedImmune Inc. | 03/31/06 | $498.00 | $374.90 | 75.3%
|
| NABI | Nabi Biopharmaceuticals | 04/01/06 | $27.55 | $11.94 | 43.3%
|
| NBIX | Neurocrine Biosciences Inc. | 03/31/06 | $19.48 | $19.48 | 100.0%
|
| ONXX | Onyx Pharmaceuticals Inc. | 12/31/05 | N/A | $0.00 | N/A
|
| PGNX | Progenics Pharmaceuticals Inc. | 12/31/05 | $2.05 | -$18.37 | N/A
|
| PHRM | Pharmion Corp. | 03/31/06 | $56.59 | $41.38 | 73.1%
|
| TELK | Telik Inc. | 12/31/05 | N/A | $0.00 | N/A
|
| VRTX | Vertex Pharmaceuticals Inc. | 03/31/06 | $39.09 | $36.09 | 92.3% |
Data: Capital IQ
Related:
- Most recent opinion and analysis of Biotech stocks
- Full transcripts of recent conference calls in the Biotech sector
- Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?
Related Articles
|




















